Assessment of hypothyroidism among adult patients suffering from beta thalassemia major
Mansoura Medical Journal · 01.01.2023 · 52 (1)
DOI: 10.58775/2735-3990.1376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mansoura Medical Journal, online erschienen am 01.01.2023. Verfasst von Ahmed Saleh Ibrahim und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Although beta thalassemia major (BTM) patients are properly treated with blood transfusions in accompany with iron chelation therapy, they suffer from serious complications such as hypothyroidism.
Aim
This work aims to assess hypothyroidism among adult with β-thalassemia major patients and to find out its association with various parameters such as age, body mass index (BMI) ,gender ,hemoglobin(Hb) and serum ferritin levels.
Methods
This cross-sectional study included 200 adult BTM patients (males 115 and females 85 ; mean age 24.684 ±5.30761 years; ranging from 18 to 43 years old). Statistical data analysis was performed using IBM-SPSS software package version 26.0.
Results
The overall frequency of hypothyroidism was 9.5%.The maximum frequency was 3.5% within the age group (27-
Zitieren
APA
Ibrahim, A. S., El-Fatah, A. H. A., El-Halim, A. F. A., & Mohamed, F. F. (2023). Assessment of hypothyroidism among adult patients suffering from beta thalassemia major. Mansoura Medical Journal, 52(1). https://doi.org/10.58775/2735-3990.1376
Vancouver
Ibrahim AS, El-Fatah AHA, El-Halim AFA, Mohamed FF. Assessment of hypothyroidism among adult patients suffering from beta thalassemia major. Mansoura Medical Journal. 2023;52(1). doi:10.58775/2735-3990.1376
BibTeX
@article{Ibrahim2023,
author = {Ibrahim, Ahmed Saleh and El-Fatah, Azza Hasan Abd and El-Halim, Ayman Fathy Abd and Mohamed, Fared Fawzy},
title = {Assessment of hypothyroidism among adult patients suffering from beta thalassemia major},
journal = {Mansoura Medical Journal},
year = {2023},
volume = {52},
number = {1},
doi = {10.58775/2735-3990.1376}
}
EUVIMED